Bernstein Remains a Buy on AstraZeneca (AZN)

Tip Ranks
2025.11.14 07:25
portai
I'm PortAI, I can summarize articles.

Bernstein Remains a Buy on AstraZeneca (AZN)

Bernstein analyst Justin Smith maintained a Buy rating on AstraZeneca today and set a price target of £184.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Smith is a 4-star analyst with an average return of 8.2% and a 60.87% success rate. Smith covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and arGEN X.

In addition to Bernstein, AstraZeneca also received a Buy from Berenberg Bank’s Luisa Hector in a report issued on November 11. However, on November 12, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.